Skip to Content

GSI 705 (Truvada 167 mg / 250 mg)

Generic Name: emtricitabine/tenofovir

Pill with imprint GSI 705 is Blue, Capsule-shape and has been identified as Truvada 167 mg / 250 mg. It is supplied by Gilead Sciences, Inc..

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 705

Truvada

Generic Name:
emtricitabine/tenofovir
Imprint:
GSI 705
Strength:
167 mg / 250 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-0705

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide